EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SIRT7 promotes lung cancer progression by destabilizing the tumor suppressor ARF

Poonam Kumari iD, Shahriar Tarighi iD, Eva Fuchshuber, Luhan Li, Irene Fernández-Duran, Meilin Wang, Joshua Ayoson, Jose Manuel Castelló-García, Andrés Gámez-García, Maria Espinosa-Alcantud, Krishnamoorthy Sreenivasan, Stefan Guenther und 6 weitere

Proceedings of the National Academy of Sciences · 18.06.2024 · 121 (25)

DOI: 10.1073/pnas.2409269121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 13.06.2024. Verfasst von Poonam Kumari und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Development and Remodeling, Max-Planck-Institute for Heart and Lung Research, Bad Nauheim 61231, Germany. Hauptthemen laut MEDLINE: Sirtuins, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Cell Proliferation. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG), EC | Horizon Europe | Excellent Science | HORIZON EUROPE Marie Sklodowska-Curie Actions (MSCA).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sirtuin 7 (SIRT7) is a member of the mammalian family of nicotinamide adenine dinucleotide (NAD + )-dependent histone/protein deacetylases, known as sirtuins. It acts as a potent oncogene in numerous malignancies, but the molecular mechanisms employed by SIRT7 to sustain lung cancer progression remain largely uncharacterized. We demonstrate that SIRT7 exerts oncogenic functions in lung cancer cells by destabilizing the tumor suppressor alternative reading frame (ARF). SIRT7 directly interacts with ARF and prevents binding of ARF to nucleophosmin, thereby promoting proteasomal-dependent degradation of ARF. We show that SIRT7-mediated degradation of ARF increases expression of protumorigenic genes and stimulates proliferation of non-small-cell lung cancer (NSCLC) cells both in vitro and in vivo in a mouse xenograft model. Bioinformatics analysis of transcriptome data from human lung adenocarcinomas revealed a correlation between SIRT7 expression and increased activity of genes normally repressed by ARF. We propose that disruption of SIRT7–ARF signaling stabilizes ARF and thus attenuates cancer cell proliferation, offering a strategy to mitigate NSCLC progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SirtuinsLung NeoplasmsCarcinoma, Non-Small-Cell LungCell ProliferationDisease ProgressionHumansAnimalsMiceGene Expression Regulation, NeoplasticCell Line, Tumor

Stichwörter der Autor:innen

ARFSIRT7Sirtuinslung cancernucleophosmin

Substanzen

SirtuinsSIRT7 protein, human

Autor:innen und Institutionen

  • Department of Cardiac Development and Remodeling, Max-Planck-Institute for Heart and Lung Research, Bad Nauheim 61231, Germany.
  • School of Medicine, Nankai University, Tianjin 300071, China.
  • Chromatin Biology Laboratory, Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia 08916, Spain.
  • Department of Lung Development and Remodeling, Max-Planck-Institute for Heart and Lung Research, Bad Nauheim 61231, Germany.
  • Facultat de Ciències, Tecnologia I Enginyeries, Universitat de Vic-Universitat Central de Catalunya, Vic, Barcelona 08500, Spain.
  • Institut de Recerca i Innovació en Ciències de la Vida i de la Salut a la Catalunya Central, Vic, Barcelona 08500, Spain.

ORCID-Profile: Poonam Kumari, Shahriar Tarighi, Rajkumar Savai, Shijing Yue, Alejandro Vaquero, Thomas Braun, Alessandro Ianni

Förderung

  • Deutsche Forschungsgemeinschaft (DFG)
  • EC | Horizon Europe | Excellent Science | HORIZON EUROPE Marie Sklodowska-Curie Actions (MSCA)

Zitieren

APA

Kumari, P., Tarighi, S., Fuchshuber, E., Li, L., Fernández-Duran, I., Wang, M., Ayoson, J., Castelló-García, J. M., Gámez-García, A., Espinosa-Alcantud, M., Sreenivasan, K., Guenther, S., Olivella, M., Savai, R., Yue, S., Vaquero, A., Braun, T., & Ianni, A. (2024). SIRT7 promotes lung cancer progression by destabilizing the tumor suppressor ARF. Proceedings of the National Academy of Sciences, 121(25). https://doi.org/10.1073/pnas.2409269121

Vancouver

Kumari P, Tarighi S, Fuchshuber E, Li L, Fernández-Duran I, Wang M, et al. SIRT7 promotes lung cancer progression by destabilizing the tumor suppressor ARF. Proceedings of the National Academy of Sciences. 2024;121(25). doi:10.1073/pnas.2409269121

BibTeX
@article{Kumari2024,
  author = {Kumari, Poonam and Tarighi, Shahriar and Fuchshuber, Eva and Li, Luhan and Fernández-Duran, Irene and Wang, Meilin and Ayoson, Joshua and Castelló-García, Jose Manuel and Gámez-García, Andrés and Espinosa-Alcantud, Maria and Sreenivasan, Krishnamoorthy and Guenther, Stefan and Olivella, Mireia and Savai, Rajkumar and Yue, Shijing and Vaquero, Alejandro and Braun, Thomas and Ianni, Alessandro},
  title = {SIRT7 promotes lung cancer progression by destabilizing the tumor suppressor ARF},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {25},
  doi = {10.1073/pnas.2409269121}
}
Kostenlos starten →